Overview

Uterotonics for Severe Preeclampsia

Status:
Completed

Trial end date:
2021-02-10

Target enrollment:

Participant gender:

Summary

The study compares the effect of Intravenous carbetocin versus combined use of intravenous oxytocin and rectal misoprostol for prevention of postpartum hemorrhage during delivery of women with severe preeclampsia

Phase:

N/A

Details

Lead Sponsor:

Assiut University

Treatments:

Carbetocin
Misoprostol
Oxytocin